Navigation Links
PharmaTelevision Turns the Media Spotlight Upon BIO-Europe
Date:10/14/2009

OXFORD, England, October 14 /PRNewswire/ -- PharmaTelevision(R), the authoritative channel for the pharmaceutical, biotechnology and related industries, today announced that it is teaming up with the EBD Group to offer delegates at BIO-Europe a Television Interview and Media Training.

Dr Fintan Walton, CEO of PharmaVentures - the company behind PharmaTelevision - said, "Standing out and attaining share of voice is becoming increasingly difficult in the crowded world of biopharma partnering. Effective communication that makes an impact is critical for attracting partners and winning deals. That is why we have devised this unique package for BIO-Europe delegates."

Dr Walton continues, "By offering media training, we are helping to make our interviewees excellent communicators through the medium of television."

To find out more about BIO-Europe 2009: Television Interview and Media Training Opportunity from PharmaTelevision, please visit:

http://www.pharmatelevision.com/BIOEurope2009.aspx

About PharmaTelevision(R)

PharmaTelevision is the groundbreaking online TV channel for the biopharma industry, offering daily television news, analysis and feature interviews with industry leaders. Since May 2006, it has rapidly grown and the channel now boasts a global audience of 10,000+ viewers including top industry executives.

PharmaTelevision is produced by professional television industry experts using professional studios worldwide as well as its own studios in Oxford, England.

PharmaTelevision produces Open Access Content as well as subscription based Premium Content.

Open Access Content includes the Regional Report - a programme that focuses on the key locations for pharmaceutical and biotech investment, the Financial Report - a programme focused on companies and their performance and the Business Network - a series of interviews and profiles of some of the leading companies in biotech.

Premium Content includes PharmaTelevision News - a daily news and analysis programme, PharmaTelevision News Review - a programme featuring interviews, panel discussions and analysis with leading experts and leaders in our industry and the Business Report - a programme that analyses key business and market trends in our industry.

About PharmaVentures

A leading results driven organisation, PharmaVentures ( http://www.pharmaventures.com) assists pharmaceutical and biotechnology companies across the world in all aspects of deal making and business intelligence. The Company provides tailored corporate advisory services to the Life Science industry, with additional deal making support provided through the PharmaDeals(R) range of intelligence products that include analysis tools and reports. An innovative business, PharmaVentures additionally provides industry insight through the world's first dedicated online pharmaceutical television channel http://www.pharmatelevision.com.

Now in its 17th year, PharmaVentures is based in Oxford, UK, employs over 50 people mostly educated to PhD or above, and has increased its turnover five fold with 80% of revenues from outside the UK. With offices in the USA and Australia, the Company works for a variety of clients from start-ups to global corporate pharmaceutical companies.

PharmaTelevision(R) and PharmaDeals(R) are registered Trade Marks of PharmaVentures Ltd.

SOURCE PharmaTelevision


'/>"/>
SOURCE PharmaTelevision
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
2. Toward worlds smallest radio: nano-sized detector turns radio waves into music
3. One of Nations Oldest Blood Services Providers Turns to Sysmex America
4. Cystic Fibrosis Trial In Children Returns Positive Data
5. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
6. Online Career Service Turns Focus to Switching Gears
7. NanoMedicine Summit Returns to Cleveland, September 25-26
8. MEDICA 2008 Returns in November
9. Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan
10. Court of Appeals Overturns 2005 Patent Verdict Against Cordis
11. Marriott Resort Magically Turns Brown Grease "Green" With The Cost-Cutting Hydrologix GRS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... RoviSys, ... services based in Aurora, Ohio, has broken ground on a new building in ... Triangle Park area, this new location solidifies a commitment to business in the ...
(Date:5/20/2016)... ... , ... Kablooe Design, a leading provider of product design and development services ... the business. “We have worked hard to build long-term relationships,” says President and CEO, ... honor of serving their product design and development needs through the years.” , Kablooe ...
(Date:5/19/2016)... RIDGE, British Columbia , May 19, 2016 ... AdvanTec Global Innovations Inc. (AGI), based out of ... recently added Greenlane Biogas Ltd. to its existing ... 2-year contract manufacturing agreement. AFS along with its ... Technologies (ABT) is a vertically integrated industrial group ...
(Date:5/19/2016)... May 19, 2016 - I ... orale durante il 52 ° ...    - Le conclusioni dello studio indicano ... pazienti trattati, di cui il 90% presenta una d ... o più. Il settantadue per cento dei pazienti ha riscontrato ...
Breaking Biology Technology:
(Date:3/14/2016)... -- NXTD ) ("NXT-ID" or the "Company"), a ... airing of a new series of commercials on Time Warner ... st .  The commercials will air on Bloomberg TV, Fox ... Street show. --> NXTD ) ("NXT-ID" or the ... announces the airing of a new series of commercials on ...
(Date:3/11/2016)... 11, 2016 --> ... report "Image Recognition Market by Technology (Pattern Recognition), by ... by Deployment Type (On-Premises and Cloud), by Industry Vertical ... by MarketsandMarkets, the global market is expected to grow ... Billion by 2020, at a CAGR of 19.1%. ...
(Date:3/9/2016)... YORK , March 9, 2016 This ... and future states of the RNA Sequencing (RNA Seq) ... segments such as instruments, tools and reagents, data analysis, ... Analyze various segments of the RNA-Sequencing market such as ... services Identify the main factors affecting each segment and ...
Breaking Biology News(10 mins):